P454: Improvement in refractory bone pain with infliximab in an adolescent with Camurati-Engelmann disease
Saved in:
| Main Authors: | Luis Delgado, Kathryn Singh, Roy Nattiv, Natalie Gallant |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Genetics in Medicine Open |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2949774425013603 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progressive diaphysiary dysplasia or Camurati-Engelmann syndrome: First case with molecular analysis in Mexico
by: De la Torre-Saldaña Viridiana Abigahy, et al.
Published: (2025-06-01) -
Successful Long-Term Use of Infliximab in Refractory Pouchitis in an Adolescent
by: Jessica Yeates, et al.
Published: (2010-01-01) -
Review: Reading Wittgenstein's Tractatus (ENGELMANN, MAURO L.)
by: Bruno Rollemberg, et al.
Published: (2022-10-01) -
Infliximab for Idiopathic Deep Cutaneous Vasculitis Refractory to Cyclophosphamide
by: Marcelo Derbli Schafranski, et al.
Published: (2010-01-01) -
Successful Discontinuation of Infliximab in a Refractory Case of Vasculo-Behçet Disease
by: Akihiro Nakamura, et al.
Published: (2016-01-01)